Pediatric Gastrointestinal Lymphoma Study
Pediatric Gastrointestinal Lymphoma Study
166]
ORIGINAL ARTICLE
Access this article online Six cases of pediatric GI lymphoma were identified over
Quick Response Code: a period of 3 years. The age at presentation ranged from
Website:
[Link] 1 to 8 years. All of these patients were boys except one
girl child who presented at a very early age (1 year). The
DOI:
commonest presentation was intestinal obstruction present
10.4103/0971-5851.89786 in three of the six (50%) patients. Other presentations
included asymptomatic abdominal lump, abdominal
92 Indian Journal of Medical and Paediatric Oncology | Apr-Jun 2011 | Vol 32 | Issue 2
[Downloaded free from [Link] on Wednesday, September 28, 2016, IP: [Link]]
Treatment
colon, respectively, with thickening of their walls. One
of the lesions in the terminal ileum was accompanied by
regional lymphadenopathy.
Ki67
100
(%)
99
46
56
54
72
Histology of the lesions showed classical Burkitt lymphoma
(BL) in one case with diffuse sheets of small tumor
+
+
+
+
+
-
cells having round to oval nuclei and several prominent
basophilic nucleoli. The chromatin was coarse and nuclear
+
-
-
membrane was thick. This case showed a prominent starry-
+
-
-
-
-
-
marker CD20, negative for CD3, Tdt and showed a high
proliferative index [Figure 2]. In the second case from
-
-
-
-
-
-
terminal ileum, the cells were larger and more atypical with
few binucleate forms. This tumor also showed a very high
+
+
+
+
+
+
proliferative index and was diagnosed as atypical Burkitt.
-
-
-
-
-
-
The remaining four cases showed histology of a diffuse
large cell lymphoma and were positive for B-cell marker St. Jude’s
CD20 and negative for CD3 [Figure 3]. stage
III
III
II
II
II
II
None of these patients showed generalized lymphadenopathy
Atypical Burkitt
DLBCL
DLBCL
DLBCL
DLBCL
Burkitt
having atypical BL on histology developed a nodule on the
lateral side of the back, approximately 2 cm in diameter,
15 days after the operative procedure. Another patient
Abdominal pain and vomiting
Intestinal obstruction
Ileocecal mass
Presentation
Terminal ileum
M Sigmoid colon
M Ileocecal
8
5
1
7
5
3
1
Indian Journal of Medical and Paediatric Oncology | Apr-Jun 2011 | Vol 32 | Issue 2 93
[Downloaded free from [Link] on Wednesday, September 28, 2016, IP: [Link]]
Figure 1: Photomicrograph showing the typical starry-sky appearance Figure 2: Photomicrograph showing high Ki67 index in a case of
of a case of Burkitt lymphoma (H and E, ×400) atypical Burkitt lymphoma (Ki67 immunostaining, ×400)
Figure 3: Photomicrograph showing CD20 positive cells in a case of Figure 4: Photomicrograph showing diffuse infiltration of large lymphoid
diffuse large B-cell lymphoma (CD20 immunostaining, ×400) cells in between skeletal muscle fibers (H and E, ×400)
94 Indian Journal of Medical and Paediatric Oncology | Apr-Jun 2011 | Vol 32 | Issue 2
[Downloaded free from [Link] on Wednesday, September 28, 2016, IP: [Link]]
compared to stage III and IV.[13] All six patients in this series like lymphoma from cases of DLBCL. Detailed study
did well in the postoperative period and all of them were of morphology, immunohistochemistry and proliferative
given systemic chemotherapy. Histologically, four of our cases index would help in solving that issue.
were diagnosed as DLBCL based on cellular morphology and
immunohistochemistry. In a study from Pakistan, they have REFERENCES
noticed predominance of high-grade lymphomas with diffuse
large B-cell, Burkitt and Burkitt-like lymphoma.[7] Western 1. Pickett LK, Briggs HC. Cancer of the gastrointestinal tract in
literature also reports a high incidence of BL but a lower childhood. Pediatr Clin North Am 1967;14:223-34.
2. Ladd AP, Grosfeld JL. Gastrointestinal tumors in children and
incidence of DLBCL.[9] Out of six cases we encountered, only adolescents. Semin Pediatr Surg 2006;15:37-47.
one case of BL and one terminal ileal growth was diagnosed 3. Dawson I, Cornes J, Morson B. Primary malignant lymphoid
as “Burkitt-like lymphoma”. The diagnosis was based on tumors of the intestinal tract. Report of 37 cases with a study
of factors influencing prognosis. Br J Surg 1961;49:80-9.
neoplastic cells showing wider range of nuclear size and 4. Magrath IT. Malignant Non-Hodgkin’s lymphoma in children.
shape along with fewer and larger nucleoli.[14] These cellular In: Pizzo PA, Poplack DG, editors. Principles and Practice of
features lead to difficulties in differentiating these variants Pediatric Oncology. 4th ed. Philadelphia: Lippincott Williams
from large B-cell lymphoma. The WHO committee suggests and Wilkins; 2002. p. 661-705.
5. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin’s
that a Burkitt-like lymphoma diagnosis should be made in lymphoma in childhood. N Engl J Med 1996;334:1238-48.
tumors with morphologic features intermediate between BL 6. Murphy SB. Classification, staging, and end results of treatment
and DLBCL, in which Ki67 fraction of viable cells is at least of childhood Non-Hodgkin’s lymphomas: Dissimilarities from
lymphoma in adults. Semin Oncol 1980;7:332-9.
99% or a c-MYC translocation is present.[14] The case of 7. Khurshed A, Ahmed R, Bhurgri Y. Primary gastrointestinal
Burkitt-like lymphoma in the present series showed a very malignancies in childhood and adolescence: An Asian
high proliferative index. perspective. Asian Pac J Cancer Prev 2007;8:613-7.
8. Bethel CA, Bhattacharyya N, Hutchinson C, Ruymann F,
Cooney DR. Alimentary tract malignancies in children. J
The ideal treatment approach in GI lymphoma remains Pediatr Surg 1997;32:1004-8.
controversial. Surgical resection should always be attempted 9. Morsi A, Abd El-Ghani Ael-G, El-Shafiey M, Fawzy M, Ismail
H, Monir M. Clinico-pathological features and outcome of
for localized disease. The approach to extensive gut management of pediatric gastrointestinal lymphoma. J Egypt
lymphoma varies widely amongst physicians. A conservative Natl Canc Inst 2005;17:251-9.
approach consists of limited resection of obstructed or 10. Jacobson MA, Hutcheson AC, Hurray DH, Metcalf JS, Thiers
perforated segment, followed by whole abdomen radiation. BH. Cutaneous involvement by Burkitt lymphoma. J Am
Acad Dermatol 2006;54:1111-3.
However, several authors have argued for aggressive surgical 11. Zaatari GS, Chan WC, Kim TH, Williams DL, Kletzel M. Malignant
debulking of all intestinal lymphomas, including stage III lymphoma of the skin in children. Cancer 1987;59:1040-5.
or IV disease.[15,16] Radical tumor resection followed by 12. Attili VS, Batra U, Bapsy PP, Lokanatha D, Clementeena R, Varma
PP, et al. Skin nodules as a presenting feature of diffuse large
chemotherapy in early disease, and limited or no resection B-cell gastric lymphoma. Indian J Dermatol 2008;53:39-40.
followed by polychemotherapy in advanced disease may 13. Ford EG. Gastrointestinal tumors. In: Andrassy R, editor.
be the justified approach. However, recent studies have Pediatric Surgical Oncology. Philadelphia, PA: WB Saunders
Co.; 1998. p. 289-304.
proposed the use of chemotherapy alone as an effective 14. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK,
treatment option in primary GI lymphoma in all stages.[17] Vardiman J, et al. World Health Organization classification of
Larger randomized studies with long follow-up are required neoplastic diseases of the hematopoietic and lymphoid tissues:
Report of the Clinical Advisory Committee meeting-Airlie House,
to reach a consensus regarding the treatment of primary GI Virginia, November 1997. J Clin Oncol 1999;17:3835-49.
lymphoma. Despite controversies regarding treatment, the 15. Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L.
disease stage at presentation remains the most important Gastrointestinal involvement in non-Hodgkin’s lymphoma.
Cancer 1980;46:215-22.
criterion determining survival.[18] In the present study, only 16. Rackner VL, Thirlby RC, Ryan JA Jr. Role of surgery in
patients with stage III disease had poor outcome. Histologic multimodality therapy for gastrointestinal lymphoma. Am J
type of the disease did not affect the survival. Whether Surg 1991;161:570-5.
this could be due to the limited resection offered to these 17. Raina V, Sharma A, Vora A, Shukla NK, Deo SV, Dawar R. Primary
gastrointestinal non-Hodgkin lymphoma chemotherapy alone
patients cannot be commented on. This would need a larger an effective treatment modality: Experience from a single
sample with randomized therapeutic approach. center in India. Indian J Cancer 2006;43:30-5.
18. Zinzani PL, Magagnoli M, Pagliani G, Bendandi M, Gherlinzoni F,
Merla E, et al. Primary intestinal lymphoma: Clinical and therapeutic
To conclude, we noticed a higher prevalence of DLBCL features of 32 patients. Haematologica 1997;82:305-8.
amongst primary pediatric GI lymphomas. Another study
from an Asian perspective had shown similar results.[7]
How to cite this article: Bandyopadhyay R, Sinha SK, Chatterjee U,
However, the number of cases in our study is small Nag D, Mukhopadhyay S, Chowdhury SR et al. Primary pediatric
and studies with large number of patients are required gastrointestinal lymphoma. Indian J Med Paediatr Oncol
to substantiate these findings in the Indian context. In 2011;32:92-5.
Source of Support: Nil, Conflict of Interest: None declared.
addition, one should be careful to differentiate Burkitt-
Indian Journal of Medical and Paediatric Oncology | Apr-Jun 2011 | Vol 32 | Issue 2 95